Inhibition of FLT3-mediated transformation by use of a tyrosine kinase inhibitor. | Leukemia;15(7): 1001-10, 2001 Jul. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Inhibition of FLT3-mediated transformation by use of a tyrosine kinase inhibitor.

Tse, K F; Novelli, E; Civin, C I; Bohmer, F D; Small, D.

Affiliation

Tse KF; Johns Hopkins University School of Medicine, Department of Oncology, Baltimore, MD, USA.

Leukemia ; 15(7): 1001-10, 2001 Jul.

Article in En | MEDLINE | ID: mdl-11455967

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Cell Transformation, Neoplastic / Proto-Oncogene Proteins / Receptors, Platelet-Derived Growth Factor / Receptor Protein-Tyrosine Kinases / Tyrphostins / Enzyme Inhibitors / Milk Proteins Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2001 Document type: Article Affiliation country: Country of publication:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Cell Transformation, Neoplastic / Proto-Oncogene Proteins / Receptors, Platelet-Derived Growth Factor / Receptor Protein-Tyrosine Kinases / Tyrphostins / Enzyme Inhibitors / Milk Proteins Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2001 Document type: Article Affiliation country: Country of publication: